NCT00525330
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of KRP-104 in Patients With Type 2 Diabetes Inadequately Controlled on Metformin Alone
Phase: Phase 2
Role: Lead Sponsor
Start: Sep 30, 2007
Completion: Aug 31, 2008